BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0024
+0.0001 (4.35%)
At close: Mar 20, 2026
BioSenic Market Cap
BioSenic has a market cap or net worth of €1.57 million as of March 20, 2026. Its market cap has increased by 9.79% in one year.
Market Cap
1.57M
Enterprise Value
24.59M
Revenue
-2.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 7.09M to 1.57M, a decrease of -77.91%. That is a compound annual growth rate of -35.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.57M | 4.35% |
| Dec 31, 2025 | 1.50M | -20.08% |
| Dec 31, 2024 | 1.88M | -81.19% |
| Dec 29, 2023 | 9.99M | 233.11% |
| Dec 30, 2022 | 3.00M | -57.74% |
| Oct 26, 2022 | 7.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.94B |
| argenx SE | 36.29B |
| Financière de Tubize | 9.08B |
| Onward Medical | 193.79M |
| Hyloris Pharmaceuticals | 157.36M |
| European Medical Solutions | 21.16M |
| Celyad Oncology | 14.77M |
| Oxurion NV | 392.55K |